Moreover, a high expression of KIF2C has been associated with advanced TNM stage in NSCLC patients, especially in the most important and common type of lung adenocarcinoma, and consequently with a dramatically decreased OS (Figure 3(B) and Table 1) [161,162]. The gene discussed is KIF2C; the disease is non-small cell lung carcinoma.